Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2004 December;56(4) > Minerva Urologica e Nefrologica 2004 December;56(4):339-42

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2004 December;56(4):339-42

language: English

Renal effects of PPARα-agonists

Izzedine H., Launay-Vacher V., Baumelou A., Deray G.

Department of Nephrology Pitie Salpetriere Hospital, Paris, France


PDF  


Peroxisome proliferator-activated receptor α (PPARα) is a member of the large nuclear receptor superfamily. Its main role is to activate genes involved in fatty acid oxidation in the liver, heart, kidney and skeletal muscle. While they are mainly used as hypolipidemic agents, PPARα agonists may also be postulated to exhibit renoprotective effects. This review summarizes current knowledge regarding the effects of PPARα agonists on the kidney.

top of page

Publication History

Cite this article as

Corresponding author e-mail